These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3363650)

  • 41. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quadruple immunosuppression in a pig model of small bowel transplantation.
    Gruessner RW; Fasola C; Fryer J; Nakhleh RE; Kim S; Gruessner AC; Beebe D; Moon C; Troppmann C; Najarian JS
    J Surg Res; 1996 Feb; 61(1):260-6. PubMed ID: 8769976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship of cyclosporine pharmacokinetic parameters to clinical events in human renal transplantation.
    Savoldi S; Kahan BD
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):120-8. PubMed ID: 3538564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of cyclosporine on canine lymphocyte activity.
    Payne JA; Herrod HG; Buice R
    J Clin Lab Immunol; 1986 Aug; 20(4):177-81. PubMed ID: 3531520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporine alone or in combination with prednisone in cadaveric renal transplantation.
    Thiel G; Harder F; Loertscher R; Brünisholz M; Landmann J; Brunner F; Follat F; Wenk M; Mihatsch M
    Transplant Proc; 1984 Oct; 16(5):1187-90. PubMed ID: 6385374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ciclosporin dose-response relationship in heart transplant recipients as calculated from HPLC determinations.
    Hamilton G; Havel M; Laczkovics A; Mühlbacher F
    Bibl Cardiol; 1988; (43):39-41. PubMed ID: 3067721
    [No Abstract]   [Full Text] [Related]  

  • 48. Cyclosporine immunosuppression.
    Canafax DM; Ascher NL
    Clin Pharm; 1983; 2(6):515-24. PubMed ID: 6360494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporine--mechanism of action.
    Drugge RJ; Handschumacher RE
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):301-9. PubMed ID: 3284073
    [No Abstract]   [Full Text] [Related]  

  • 50. Ciclosporin in renal transplantation.
    Land W; Castro LA; White DJ; Hillebrand G; Hammer C; Klare B; Fornara P
    Prog Allergy; 1986; 38():293-328. PubMed ID: 3523493
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival.
    Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ
    Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961
    [No Abstract]   [Full Text] [Related]  

  • 52. Ketoconazole potentiates cyclosporine immunosuppression and toxicity in mice.
    Anderson JE; Morris RE; Blaschke TF
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1267-8. PubMed ID: 3274315
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine.
    Martinelli GP; Chung-Loy R; Sher L; Racelis D; Miller CM; Schanzer H
    Transplantation; 1985 Jan; 39(1):1-5. PubMed ID: 3880956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
    J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model.
    Granger DK; Cromwell JW; Canafax DM; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):984. PubMed ID: 8623488
    [No Abstract]   [Full Text] [Related]  

  • 56. Discontinuation of one drug in triple-drug immunosuppression with cyclosporine, azathioprine, and steroids: an interim report.
    Häyry P; Ahonen J; von Willebrand E; Eklund B; Höckerstedt K; Isoniemi H; Grönhagen-Riska C
    Transplant Proc; 1988 Jun; 20(3):449-50. PubMed ID: 3381256
    [No Abstract]   [Full Text] [Related]  

  • 57. Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.
    Morales JM; Muñoz MA; Campo C; Andres A; Araque A; Alamo C; Praga M; Ortuño T; Hernandez E; Rodicio JL
    Transplant Proc; 1994 Oct; 26(5):2511-2. PubMed ID: 7940770
    [No Abstract]   [Full Text] [Related]  

  • 58. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma.
    Suh MY; Wang K; Gutweiler JR; Misra MV; Krawczuk LE; Jenkins RL; Lillehei CW; Jonas MM; Kim HB
    J Pediatr Surg; 2008 Jun; 43(6):1148-52. PubMed ID: 18558198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of cyclosporine on anesthetic action.
    Cirella VN; Pantuck CB; Lee YJ; Pantuck EJ
    Anesth Analg; 1987 Aug; 66(8):703-6. PubMed ID: 3605689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
    Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.